Advertisement · 728 × 90

Posts by Chris Nickson

Great work led by Dr Ken Hoffman on the CICM second part exam vivas www.sciencedirect.com/science/arti...

2 months ago 3 0 1 0
Preview
RSI: Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults Casey. NEJM. 2025. doi: 10.1056/NEJMoa2511420 Clinical Question Among adults with non‑traumatic critical illness undergoing emerg...

RSI: Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults – The Bottom Line #foamed #foamcc

www.thebottomline.org.uk/summaries/ic...

4 months ago 8 5 0 0
Preview
Etomidate Pharmacology of etomidate (Critical Care Compendium entry)

Etomidate • LITFL Critical Care Compendium #foamed #foamcc

Comprehensive overview of etomidate pharmacology for critical care clinicians including implications from the RSI trial

litfl.com/etomidate/

4 months ago 3 1 0 1
Post image Post image

Pity they massively overdosed the ketamine arm - significant percentage > 2mg/kg / no ceiling dose ("rule of 1 ampoule") / dose per total body weight / and who gives > 0.5 mg/kg to a "sick" patient - great trial / wrong pharmacology / wrong conclusion = drugs are equivalent at equipotent doses

4 months ago 7 2 0 2
Post image

The Worlds Best Intensive Care Meeting is up and running -
Critical Care Reviews Down Under - triallist, editorialist, statistician, expert panel - an hour - not 10 mins - and that is the outside behind them - Naarm (Melbourne)

4 months ago 3 1 0 0
4 months ago 13 2 3 0
Video

Co-Chief Investigators Jonathan Casey and Matthew Semler share their insights from the #RSI trial after presenting at #CCRdownunder

Livestream -> www.criticalcarereviews.com

@jama.com

4 months ago 5 2 0 0
CCR Down Under 2025 
Original Article | Dec. 9, 2025 | NEJM.org 
Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults 

Figure 1. In-Hospital Death, According to Trial Group. 

The NEJM identity sits at the bottom.

CCR Down Under 2025 Original Article | Dec. 9, 2025 | NEJM.org Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults Figure 1. In-Hospital Death, According to Trial Group. The NEJM identity sits at the bottom.

In a randomized trial involving critically ill patients undergoing intubation in EDs or ICUs, the use of ketamine for the induction of anesthesia did not lead to significantly lower in-hospital mortality than etomidate. Full trial results: nej.md/44EOlxB

@criticalcarereviews.com

4 months ago 24 14 4 3
Video

Chief Investigator Arthur Kwizera shares an overview of the #ARISEAFRICA trial after presenting at #CCRdownunder and highlights what clinicians can take away from the results.

Livestream -> www.criticalcarereviews.com

@jama.com

4 months ago 2 2 0 1
Advertisement
Video

Co-Chief Investigators Brenda O'Neill and Danny McAuley share the results of the #iRehab trial after presenting at #CCRdownunder

Livestream -> www.criticalcarereviews.com

@jama.com

4 months ago 7 5 0 0
Preview
The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting #### Summary points

#ARISEAFRICAtrial is a stepped wedge cluster- this design is useful for interventions delivered at the ICU/hospital level and individual randomisation is difficult. Clusters transition from control to intervention at different times www.bmj.com/content/350/... #ccrdownunder @criticalcarereviews.com

4 months ago 4 3 0 0
Post image

RSI trial now starting

➡️ Etomidate vs Ketamine for RSI

➡️ Jonathan Casey & Matthew Semler presenting
➡️ Chris Nickson editorialising

➡️ Join the livestream - criticalcarereviews.com

#ccrdownunder

4 months ago 11 3 0 1

Congratulations to the RSI trial team #CCRdownunder

4 months ago 4 2 2 0

Wow wow wow

Beautiful trial. Nice editorial. Worth watching if you intubate patients.

4 months ago 16 3 3 1
JAMA article "Precision Therapy for Sepsis The End of the Beginning?" by Derek C. Angus, MD, MPH. Article discusses sepsis treatment, host response, and clinical trials.

JAMA article "Precision Therapy for Sepsis The End of the Beginning?" by Derek C. Angus, MD, MPH. Article discusses sepsis treatment, host response, and clinical trials.

Editorial by JAMA Senior Editor Derek Angus: The ImmunoSep RCT demonstrates the feasibility of biomarker-guided treatment, while highlighting ongoing challenges in immune classification and broader clinical application. #CCRdownunder ja.ma/3Kg3qz3

4 months ago 7 2 0 0
Home The most up-to-date critical care website in the world

Second at #ccrdownunder - #IREHABtrial
Post your questions at #ccrdownunder and #IREHABtrial or at the livestream: criticalcarereviews.com

4 months ago 2 1 0 0
Preview
Precision Therapy for Sepsis Sepsis is a macabre dance between host and pathogen.1 With development of germ theory by Lister, Semmelweis, Pasteur, and Koch, pathogen eradication was the focus. Only in recent decades, with observa...

Precision Therapy for Sepsis: The End of the Beginning? | Critical Care Medicine | JAMA | JAMA Network #ccrdownunder 2025
jamanetwork.com/journals/jam...

4 months ago 3 1 0 0
JAMA graph titled 'Figure 2. Primary End Point'. 'Change from the baseline SOFA score' is plotted for precision immunotherapy (orange) and placebo (blue). SOFA scores range from 0 to 20; x-axis is 1 to 145.

JAMA graph titled 'Figure 2. Primary End Point'. 'Change from the baseline SOFA score' is plotted for precision immunotherapy (orange) and placebo (blue). SOFA scores range from 0 to 20; x-axis is 1 to 145.

RCT: Among patients with #sepsis, a precision immunotherapy strategy targeting macrophage activation-like syndrome and sepsis-induced immunoparalysis improved organ dysfunction by day 9 compared to placebo.#CCRdownunder ja.ma/3MkSb95

4 months ago 11 7 0 1
JAMA research summary on precision immunotherapy to improve sepsis outcomes.The trial assessed whether immunotherapy could improve organ function in sepsis-3 patients.35.1% in precision immunotherapy vs 17.9% in placebo groups.

JAMA research summary on precision immunotherapy to improve sepsis outcomes.The trial assessed whether immunotherapy could improve organ function in sepsis-3 patients.35.1% in precision immunotherapy vs 17.9% in placebo groups.

📊 Research Summary: The ImmunoSep trial demonstrates the potential for biomarker-guided immunotherapy in a subset of patients with sepsis. #CCRdownunder ja.ma/4pMi8wt

4 months ago 10 3 0 0
Advertisement

ImmunoSep uses a double-dummy design.
What is this? It is a design to maintain blinding when 2 treatments can't be made identical- all participants receive 2 treatments- one which is active and the other which is placebo #ccrdownunder

4 months ago 1 1 0 0
Preview
Precision Immunotherapy to Improve Sepsis Outcomes This randomized trial assesses whether precision immunotherapy tailored to macrophage activation–like syndrome or sepsis-induced immunoparalysis improved organ dysfunction compared with placebo among ...

IMMUNOSEP trial - JAMA jamanetwork.com/journals/jam... #ccrdownunder 2025

4 months ago 1 0 0 0

Looking forward to #ccrdownunder- if you are following along please include this hashtag in any posts and I can moderate your questions online- enjoy the live!!!

4 months ago 4 1 0 0
Home The most up-to-date critical care website in the world

Up first at #ccrdownunder - #IMMUNOSEPtrial
Post your questions at #ccrdownunder and #IMMUNOSEPtrial or at the livestream: criticalcarereviews.com

4 months ago 2 1 0 0
Post image

Struggling to keep up with the critical care literature?

➡️ We search it daily & curate the best papers
➡️ Delivered to your inbox each weekend
➡️ Try our Newsletter - there's nothing else like it

Sample - criticalcarereviews.com/newsletters/...
Subscription - criticalcarereviews.com/newsletters/...

6 months ago 1 1 0 0
Post image

There are now just under 50 days to CCR Down Under 2025.

The programme is out - 8 superb trial results coming up.

Join us in Melbourne, in person or virtually, to discuss the best critical care trials in the world!

criticalcarereviews.com/meetings/ccr...

5 months ago 9 5 0 1
Preview
CCR Down Under 2025 Critical Care Reviews Meeting Down Under - The Edge, Federation Square, Melbourne, December 9th - 10th, 2025

The 5th trial to be announced for CCR Down Under 2025 is ACTiVE

Effect of automated closed-loop ventilation versus conventional ventilation on duration and quality of ventilation in critically ill patients

Join us in Melbourne, either in-person or online
criticalcarereviews.com/meetings/ccr...

8 months ago 4 2 0 0
Preview
CCR Down Under 2025 Critical Care Reviews Meeting Down Under - The Edge, Federation Square, Melbourne, December 9th - 10th, 2025

CCR Down Under 2025 - december 9th & 10th 2025 Melbourne is the place to be! Registrations are open 😁: criticalcarereviews.com/meetings/ccr... See you there! @criticalcarereviews.com

8 months ago 4 3 1 0
Preview
CCR Down Under 2025 Critical Care Reviews Meeting Down Under - The Edge, Federation Square, Melbourne, December 9th - 10th, 2025

🚩The 3rd trial result for CCR Down Under 2025 is ARISE-AFRICA🚩

➡️Standard low flow oxygen vs nasal high flow oxygen vs CPAP in hypoxaemic respiratory failure

➡️Presenter Arthur Kwizera

➡️Join us in Melbourne
criticalcarereviews.com/meetings/ccr...

@precordialthump.bsky.social

8 months ago 4 3 0 0
Advertisement
Preview
CCR Down Under 2025 Critical Care Reviews Meeting Down Under - The Edge, Federation Square, Melbourne, December 9th - 10th, 2025

CCR Down Under 2025 - december 9th & 10th 2025 Melbourne is the place to be! Registrations are open 😁: criticalcarereviews.com/meetings/ccr... See you there! @criticalcarereviews.com

8 months ago 4 3 1 0

Looking forward to this!

9 months ago 4 2 0 0